EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Other Sources: 9

Ubiquinol

Also called: reduced coenzyme Q10, reduced CoQ10, ubiquinol-10

The reduced form of coenzyme Q10 (CoQ10), sold in capsules and in liquid form. Even when CoQ10 is taken as ubiquinone, it appears in the blood mostly as ubiquinol. General CoQ10 information is in the coenzyme Q10 entry.

Category
Other
Forms
Ubiquinol (reduced coenzyme Q10), capsules or liquid
Strongest evidence
C Limited
Reviewed
2026-10-30

Class 2 Moderately studied in people. Six randomized placebo-controlled trials of ubiquinol alone were found in five reports: Parkinson's disease (two pilot trials, 2015), antiphospholipid syndrome (2017), type 2 diabetes (2018), strenuous exercise in firefighters (2020) and a ubiquinol-alone arm in heart failure with preserved ejection fraction (2022). No systematic review stating a count was found. [1]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

5 topics studied4 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Ubiquinol does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Ubiquinol, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Parkinson's disease symptomsCPilot RCTs (300 mg/day) found improved UPDRS scores versus placebo in patients with wearing-off (48 weeks, 26 analyzed), but not in early Parkinson's disease (96 weeks, 22 analyzed). [1]
Heart failure with preserved ejection fractionCA 12-week phase 2 RCT (216 patients; ubiquinol 600 mg/day and/or D-ribose 15 g/day, factorial design) reported that ubiquinol and/or D-ribose improved symptom scores, vigor and ejection fraction; 6-minute walk did not improve. [6]
Glucose control in type 2 diabetesCA 12-week RCT (50 patients, 100 mg/day liquid ubiquinol) reported lower HbA1c than placebo (P = 0.03) and higher catalase and glutathione peroxidase activities. [3]
Blood and inflammatory markers around strenuous exerciseCIn 100 well-trained firefighters given ubiquinol or placebo before two strenuous exercise tests, ubiquinol raised red blood cells, hemoglobin and some anti-inflammatory markers and lowered IL-1, IL-8 and MCP-1. [4]
Thrombosis and inflammation markers in antiphospholipid syndromeCA 1-month randomized crossover trial (36 patients, 200 mg/day) reported improved endothelial function and lower monocyte prothrombotic and proinflammatory mediators versus placebo. [2]

Main constituents: Ubiquinol-10, the reduced form of coenzyme Q10 [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • 300 mg/day for 48 or 96 weeks (Parkinson's disease). [1]
  • 600 mg/day for 12 weeks (heart failure with preserved ejection fraction). [6]
  • 200 mg/day for two weeks (firefighters). [5]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score E
    A: well known causeE: unlikely cause

    NIH LiverTox, Coenzyme Q10 (last update April 20, 2024; lists ubiquinol among other names): likelihood score E, unlikely cause of clinically apparent …

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    2 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • NIH LiverTox (coenzyme Q10 chapter, which lists ubiquinol as another name; last update April 20, 2024): likelihood score E, unlikely cause of clinically apparent liver injury. [8]
Quality

Identity, quality and standardization

  • In a randomized crossover study in 21 healthy adults aged 65-74, ubiquinol capsules did not significantly increase CoQ10 bioavailability versus standard ubiquinone capsules (1.7-fold; 95% CI 0.9-3.1). [7]
Regulation

Regulatory status

  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [9]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Ubiquinol (reduced coenzyme Q10) Reduced form of coenzyme Q10 [P7]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 2 entries naming ubiquinol (earliest NDI 311 submitted 2004-12-03; most recent NDI 328 submitted 2005-05-05). Each notification covers one firm's specific ingredient and conditions of use; the list does not state FDA's response. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of ubiquinol or coenzyme Q10 was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-30). [P2]
  • The NTP Technical Reports index (TR-001 to TR-606) lists no 2-year study of ubiquinol or coenzyme Q10 (checked 2026-10-30). [P3]

Liver (NIH LiverTox)

  • NIH LiverTox, Coenzyme Q10 (last update April 20, 2024; lists ubiquinol among other names): likelihood score E, unlikely cause of clinically apparent liver injury. [P5]

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • Pravst et al. (2020), 21 healthy adults aged 65-74, single 100 mg doses: ubiquinol capsules gave 1.7-fold the CoQ10 exposure of ubiquinone capsules (95% CI 0.9-3.1; not significant); CoQ10 appeared in blood mostly as ubiquinol even when taken as ubiquinone. [P6]
  • LiverTox: because CoQ10 is lipid soluble, it is frequently given with lipids or vitamin E to improve absorption. [P5]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications (last update 2026-07-23; checked 2026-10-30), 2026-07-23. monographs.iarc.who.int
  3. National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-30), 2026-10-30. ntp.niehs.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, retrieved 2026-10-30), 2026-10-30. ecfr.gov
  5. NIH LiverTox. Coenzyme Q10 (Last Update: April 20, 2024), 2024-04-20. ncbi.nlm.nih.gov
  6. Pravst I, et al. Comparative bioavailability of different coenzyme Q10 formulations in healthy elderly individuals. Nutrients 2020;12(3):784 (PMID 32188111), 2020-03-16. pubmed.ncbi.nlm.nih.gov
  7. Yen CH, et al. Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial. Br J Nutr 2018;120(1):57-63 (PMID 29936921), 2018-07. pubmed.ncbi.nlm.nih.gov
Sources

Sources

  1. Yoritaka A, et al. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease. Parkinsonism Relat Disord 2015;21(8):911-6 (PMID 26054881), 2015-08. pubmed.ncbi.nlm.nih.gov
  2. Perez-Sanchez C, et al. Ubiquinol effects on antiphospholipid syndrome prothrombotic profile: a randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 2017;37(10):1923-1932 (PMID 28684614), 2017-10. pubmed.ncbi.nlm.nih.gov
  3. Yen CH, et al. Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial. Br J Nutr 2018;120(1):57-63 (PMID 29936921), 2018-07. pubmed.ncbi.nlm.nih.gov
  4. Diaz-Castro J, et al. Beneficial effect of ubiquinol on hematological and inflammatory signaling during exercise. Nutrients 2020;12(2):424 (PMID 32041223), 2020-02-06. pubmed.ncbi.nlm.nih.gov
  5. Diaz-Castro J, et al. Ubiquinol supplementation modulates energy metabolism and bone turnover during high intensity exercise. Food Funct 2020;11(9):7523-7531 (PMID 32797125), 2020-09-23. pubmed.ncbi.nlm.nih.gov
  6. Pierce JD, et al. Effects of ubiquinol and/or D-ribose in patients with heart failure with preserved ejection fraction. Am J Cardiol 2022;176:79-88 (PMID 35644694), 2022-08-01. pubmed.ncbi.nlm.nih.gov
  7. Pravst I, et al. Comparative bioavailability of different coenzyme Q10 formulations in healthy elderly individuals. Nutrients 2020;12(3):784 (PMID 32188111), 2020-03-16. pubmed.ncbi.nlm.nih.gov
  8. NIH LiverTox. Coenzyme Q10 (Last Update: April 20, 2024), 2024-04-20. ncbi.nlm.nih.gov
  9. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in this category: Alpha-lipoic acid · Bee pollen · Beetroot juice (dietary nitrate) · Berberine · Beta-glucan (oat and barley) · Betaine (trimethylglycine) · Bromelain · Caffeine · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.